ABSTRACT
INTRODUCTION
Biofeedback therapy has established its role in the treatment of patients with urinary incontinence and urologic symptoms caused by pelvic floor dysfunction (1). In functional coloproctology the results of biofeedback therapy, however, are contradictory and there are insufficient data to show which patients really benefit from this behavioral, functional treatment. This is especially the case in patients with anal incontinence (2-4).
Biofeedback therapy has been advocated for symptoms of mild to moderate fecal incontinence (5). Biofeedback alone is not indicated in patients with fecal incontinence and surgically correctable structural defect without pudendal nerve damage but may be useful in retraining the sphincters after sphincteroplasty (5, 6). There is also some evidence that biofeedback therapy is not effective in patients having bilateral pudendal neuropathy (7, 8) .
Functional constipation can be divided into three major subgroups; slow transit constipation, pelvic floor dysfunction (PFD) and combination of these entities (9). Pelvic floor dysfunction, especially paradoxic puborectalis contraction (anismus) is the main indication for biofeedback therapy in constipated patients (8, [10] [11] [12] .
In our unit, biofeedback therapy using modern equipment has been delivered since 1998 by a specialized pelvic floor therapist. The aim of this study was to review our results of biofeedback therapy in patients with anal incontinence or constipation.
MATERIAL AND METHODS
Between January 1998 and March 2002, fifty-two consecutive patients underwent biofeedback therapy for anal incontinence or constipation and outlet obstruction. There were 22 patients with anal incontinence; 21 female and one male, with a median age of 57 (range 27-84) years, and 30 patients with constipation and outlet obstruction; 22 female and 8 male, with median age of 56 (range 25-83) years. Patient selection for the treatment was made by an experienced proctologist at the outpatient department.
Patients with anal incontinence underwent clinical examination and anal endosonography. Anal manometry and assessment of the severity of symptoms was done using Wexner scale (13). Wexner score over nine after treatment was considered unsatisfactory (14) .
Patients with constipation and outlet obstruction underwent clinical examination, and symptoms of constipation were assessed by a detailed questionnaire. Patients were judged to be constipated if they had two or fewer bowel movements per week or strained for >25 percent of their defecation times (15) . Symptoms attributed to impaired bowel function included infrequent defecation ( ≤ 2/week), use of laxatives and/or enemas, presence of hard stools, and absence of normal urge to defecate. Symptoms attributed to difficult evacuation included excessive straining at defecation, a feeling of blockage, incompleteness of evacuation, and the need for digital evacuation (16) .
Other diagnostic tests, such as defecating proctogram, colonic transit study, balloon expulsion test and barium enema were used selectively according to symptoms and findings of clinical examination.
Anal manometry was performed using the low compliance system (17) . A catheter of 5 mm in diameter with four side openings perpendicular to each other, 5 cm from the sealed tip was used. Perfusion rate was 0,5 ml/min. Manometry was carried out by using station pull-through technique with 0.5 cm intervals. A 60 ml catheter-tip balloon positioned in the rectum was filled slowly with air to measure rectal sensation. Anal endosonography was done with a 10 MHz rotating probe (B & K Medical, Copenhagen, Denmark).
Puborectal electromyographic activity during attempted defecation was measured using plug EMG (Myomed 432, Enraf-Nonius, Delft, Netherlands until 2001 and from 2001 NeuroTrac EMG, Verity Medical Ltd, Surrey, UK) (18) . Paradoxical puborectalis contraction (anismus) was defined by a sustained increase in plug EMG activity (> 50 percent increase from baseline) on attempted defecation (12, 19) , Fig. 1 and 2 .
Colonic transit studies were performed with radiopaque markers in a soft gel capsule (Sitz markers, Konsyl Pharmaceuticals, Forth Worth, Tex, U.S.A) according to the technique described by Metcalf and colleagues (20) . Defecating proctogram was used to diagnose patients with outlet obstruction and rectocele. A rectocele with a size of over three cm was considered as pathological (21, 22) . Balloon expulsion test was carried out by inserting a 50 ml catheter-tip balloon filled with warm water into the rectum. The patient was asked to expel the balloon in the privacy of a restroom and the time to expel the balloon was measured (18) . Barium enema was used to rule out idiopathic megarectum (23) . All patients underwent colonoscopy to rule out any organic pathology.
Biofeedback therapy was carried out by using Endomed M-433 (Enraf-Nonius, Delft, Netherlands) device with interference current until 2001 and after that, Neurotrac 5 ETS or Neurotrac 4 device (Verity Medical Ltd, Surrey, UK). In every patient, the continuous rest tone was measured for one minute with the anal plug in place in the rectum. The investigation was done on left lateral position until 2001, and from 2001 while sitting. Abdominal muscle pressure response to pelvic floor muscles was measured. The pelvic floor muscles were warmed for testing by submaximal contractions and rest tonus was searched for by means of contractions if overtension (rest tone > 8 mV) was observed. The voluntary functions of the pelvic floor muscles were observed in three to five different positions and movements (sitting, sitting-standing-sitting, walking and stepping). Based on these measurements, a detailed individual training program was constructed for every patient. Neuromuscular electrostimulation was always used in conjunction with functional training. In patients with anal incontinence electrostimulation was used both at sensory and motoric levels in three to five minute remittent sequences with changing frequencies (20-50 Hz) (24, 25) . Therapy sessions were carried out once a week. The outcome of biofeedback therapy was assessed after the first series of treatment with median eight (range, 4-15) therapy sessions.
STATISTICAL ANALYSIS
Nonparametric data were analyzed with the MannWhitney U test for discrete variables, and nonparametric paired data were analyzed by Wilcoxon's paired signed-rank test. The two tailed t test was used to compare anal manometry results before and after treatment. Statistical comparison of symptoms before and after treatment was analyzed by McNe- mar's test (SPSS for Windows 11.5.1, SPSS Inc., Chicago, IL). A P value of <0.05 was considered statistically significant.
RESULTS

ANAL INCONTINENCE
The indications for biofeedback therapy were idiopathic incontinence (intact sphincters on anal endosonography, neither previous perineal nor rectal operations and no medical condition explaining the incontinence) in eight (36 percent), persistent incontinence after surgery for rectal prolase in five (23 percent), retraining after secondary repair for anal sphincter rupture in four (18 percent), incontinence and partial external sphincter defect in four (18 percent) and flatus incontinence after primary overlap repair for anal sphincter rupture in one patient (5 percent).
Overall, incontinence affecting quality of life was present in twenty patients (91 percent) before and eight patients (36 percent) after treatment ( P <0 Table 1 . The results of anal manometry before any treatment and after surgery and/ or biofeedback therapy are presented in Table 2 . In patients with partial anal sphincter defect, median Wexner score was 10 (range 9-11) before and 1 (range 1-3) ( P =0.066) after treatment, 16.5 (range 13-19) vs 4.5 (range 4-9) ( P =0.068) in patients retrained after secondary repair, 14 (range 6-19) vs 10 (range 6-13) ( P =0.17) in patients with idiopathic incontinence, and 13 (range 10-16) vs 8 (range 1-12) ( P =0.42, Wilcoxon's signed-rank test) in patients being incontinent after surgery for rectal prolapse, respectively. One patient with flatus incontinence after primary overlap repair scored 5 before and 0 after biofeed- Wexner score > 9 nB efore nA fter nI mproved % P value* Partial sphincter defect (n =4 . External sphincter defects were found in eight patients (36 percent) on anal endosonography. Four of these defects were only partial, consisting of scarring in less than one quadrant of the sphincter. Internal sphincter defects were found in one patient with total external sphincter rupture and in one with incontinence after surgery for rectal prolapse and previous sphincter repair. PNTML was measured in eleven patients. In patients with idiopathic incontinence, PNTML was prolonged (> 2.2 ms) bilaterally in four, unilaterally in one and normal in one out of six patients. In five patients operated for rectal prolapse, PNTML was prolonged bilaterally in one and was normal in the other four.
CONSTIPATION
Diagnostic tests before biofeedback therapy were used selectively according to clinical examination and symptoms. Colonic transit studies were assessed in twelve patients, rectal sensitivity in seventeen, pelvic floor EMG in twenty-eight, defecating proctogram in nineteen, balloon expulsion test in eleven and barium enema in four patients. The indications for biofeedback therapy were pelvic floor dysfunction in twenty-three patients (77 percent) and combined PFD and slow transit constipation in seven patients (23 percent). Constipation related symptoms are presented in Table 3 .
A sustained increase in plug EMG activity (> 50 percent increase from baseline) on attempted defecation (anismus) was found in seventeen patients (74 percent) and impaired rectal sensitivity (rectal sensory threshold for the first perception of distension >30ml) or descending perineum syndrome in six patients (23 percent) with PFD. Biofeedback therapy was successful in thirteen patients (68 percent) with PFD, in ten patients (77 percent) with anismus and in three (50 percent) having other causes. In patients with a pathological rectocele on defecating proctogram (seen in eight patients (35 percent) with PFD), biofeedback therapy was successful in 67 percent, in 75 percent of patients with anismus and in 50 percent of patients with other causes. Biofeedback was successful in 50 percent of patients with combined PFD and prolonged colonic transit time (> 72 h), Table 4.
Six of the patients with PFD did not respond to the initial course of biofeedback therapy, Table 4 . Three of these patients with anismus underwent a repeat course of biofeedback therapy with sufficient response, two patients were managed conservatively with medical treatment and colonic enemas and one patient underwent subtotal colectomy with ileorectal anastomosis. Three patients with combined PFD and colonic inertia were unresponsive to biofeedback therapy. Two of these patients were managed conservatively with medical therapy and colonic enemas and in one patient, botullinum toxin treatment led to favourable outcome.
DISCUSSION
Biofeedback therapy has been reported to be effective in about 75 percent of unselected patients with anal incontinence (2, 26, 27). However, the outcome measures used in many studies have not been validated, different scoring systems for symptoms have been used, and the impact of incontinence on patients daily life has not been taken into account (3). In our study, 60 percent of all patients with anal incontinence benefited from biofeedback therapy as judged by Wexner score ≤ 9 which is usually considered satisfactory (14) . According to Jensen and colleagues (6), biofeedback therapy improves functional outcome after sphincteroplasty. In our study, routine retraining after secondary sphincteroplasty decreased median Wexner score from 16.5 to 4.5. We also found that patients with only partial sphincter defect or mild incontinence after primary repair benefit from biofeedback therapy. In accordance to earlier studies (8, 27), the benefit was especially pronounced in patients with partial external sphincter defects with decrease of median Wexner score from 10 to one and total disappearance of incontinence symptoms affecting quality of life from 100 to 0 percent.
Prolapse surgery alone has been shown to cure incontinence in 85 percent of patients with rectal prolapse (28) . Persisting incontinence after surgery has been shown to be related to deficient internal sphincter function and/or persisting external sphincter ruptures (29) . In our study, 60 percent of patients with persisting incontinence after surgical repair of rectal prolapse benefited from biofeedback therapy. Our manometry results suggest that the external sphincter function is improved after surgery and can be further improved by biofeedback therapy. However, there is no effect on resting pressure and internal sphincter function.
Our results of biofeedback therapy were disappointing in patients with idiopathic incontinence with only two patients (29 percent) showing some benefit. This result is not in line with previous findings showing a cure rate of 57 percent in patients with structurally intact sphincters (27) . Van Tets and colleagues (7) reported biofeedback therapy to be ineffective in patients with bilateral and complete neuropathy. In four of our patients with idiopathic incontinence, pudendal nerve terminal motor latencies were prolonged bilaterally without complete neuropathy. Only one of these four patients benefited from biofeedback.
Sacral nerve stimulation (SNS) is a new promising method for managing patients with fecal incontinence not responding for conservative medical or biofeedback therapy (30) (31) (32) . This method is in use at our institution but however, because of sufficient response to loperamide or colonic enemas, none of the eight patients in this study with unsuccessful biofeedback therapy has been offered SNS.
According to Chiotakakou-Faliakou and collegues (33) biofeedback is an effective treatment in the majority of patients with constipation unresponsive to medical treatment, while others have emphasized a selective biofeedback therapy (8, 9, 34). For patients with paradoxical puborectalis contraction (anismus) biofeedback is accepted as a method of choice (9) with a success rate of 70 to 90 percent (10, (34) (35) (36) . In our study biofeedback was successful in 64 percent of all patients with constipation and outlet obstruction, but in 77 percent when the cause was purely anismus. Biofeedback significantly decreased the symptoms attributed to difficult evacuation, but contrary to previous findings there was no effect on symptoms attributed to impaired bowel function (33) . In contrast to Chiotakakou-Faliakou and collegues (33), concomitant prolonged transit time decreased the benefit of biofeedback therapy in our patients. In these patients, biofeedback resulted in a positive outcome judged by Drossman criteria (15) in only 50 percent.
CONCLUSIONS
In patients with anal incontinence, the major indications for biofeedback are retraining after sphincter repair and incontinence symptoms in patients with only partial external sphincter defects. Biofeedback is less successful in patients with idiopathic anal incontinence. Biofeedback significantly reduces symptoms attributed to difficult evacuation and is especially useful in patients with obstructed defecation caused by paradoxical puborectalis contraction.
